Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Chromadex Corp CDXC

Technology Scientific & Technical Instruments
Chromadex Corp. is a global bioscience company. The Company is engaged in research on nicotinamide adenine dinucleotide (NAD+), an essential coenzyme that is a key regulator of cellular metabolism and is found in every cell of the human body. Its segments include Consumer Products, Ingredients and Analytical Reference Standards and Services. The Consumer Products segment provides finished... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:CDXC)

ChromaDex Announces Tru Niagen® is Now Third-Party Verified Through the Alkemist Assured(TM) Transparency Program

Business Wire March 26, 2024

ChromaDex Corporation Reports Fourth Quarter and Fiscal Year 2023 Results

Business Wire March 6, 2024

ChromaDex to Report Fourth Quarter 2023 Financial Results on Wednesday, March 6, 2024

Business Wire February 21, 2024

ChromaDex to Present at the Lytham Partners 2024 Investor Select Conference

Business Wire January 26, 2024

ChromaDex Supports the US Military with its Industry Leading NAD+ Supplement, Tru Niagen®

Business Wire December 20, 2023

Neurohacker Collective and ChromaDex Partner to Optimize Cellular Health with the Debut of Qualia NAD+

PR Newswire December 12, 2023

A Milestone Phase I Randomized, Double-Blind Clinical Trial Demonstrates High-Dose Niagen®, Patented Nicotinamide Riboside (NR), Supplementation Induces a Potent NAD+ Response and Is Associated With Mild Improvement in Parkinson's Disease (PD)

Business Wire November 30, 2023

Newly Published Phase II Clinical Study Demonstrates that Supplementation with Niagen®, Patented Nicotinamide Riboside (NR), Elevates NAD+ Up to Fourfold, Improving Motor Coordination and Eye Movement in Ataxia Telangiectasia (AT) Patients

Business Wire November 15, 2023

ChromaDex to Participate in Renmark's Virtual Non-Deal Roadshow on Tuesday, November 14, 2023

Business Wire November 9, 2023
View More News ››

Opinion & Analysis (NDAQ:CDXC)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:CDXC)

Nice coverage and valuation article on Chromadex

ChromaDex: Blazing Ahead Of Ponce De Leon (NASDAQ:CDXC) | Seeking Alpha seekingalpha.com/article/4378493-chromadex-blazing-ahead-of...
jthottam - December 20, 2020

Keeping people as young and healthy as possible

sounds like a pretty good thing. Bought first shares today
scopro - May 3, 2019

This one has me fustrated.

I love the product. I use the product. But the stock is killing me. When it ran to 6 bucks. I thought, here we go. On our way to 20...
HERO547 - January 15, 2017

This report will be the game changer.

ChromaDex to Report First Quarter 2016 Financial Results on Thursday, May 12, 2016 Company Will Host Investor Conference Call on...
HERO547 - May 10, 2016

We be ringing the bell.

https://finance.yahoo.com/news/chromadex-corp-nasdaq-cdxc-ring-140000216.html
HERO547 - May 5, 2016

Getting closer to main stream news sources.

http://www.newsweek.com/vitamin-stops-aging-process-organs-study-453526
HERO547 - May 2, 2016
View more Bullboard ››

Mullen Group Ltd.

Mullen Group Ltd.

Mullen Group is one of North America's largest logistics providers with a network of independently operated businesses ...
View More »